Clinical trial
Effect of Ranibizumab on Malignant Conjunctival Neoplasia
NCT00456495 is registered in ClinicalTrials.gov with The New York Eye Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Ranibizumab on Malignant Conjunctival Neoplasia
- Lead sponsor
- The New York Eye Cancer Center
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- March 31, 2007
- Completion date
- September 30, 2010
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.